<code id='5C7D896C41'></code><style id='5C7D896C41'></style>
    • <acronym id='5C7D896C41'></acronym>
      <center id='5C7D896C41'><center id='5C7D896C41'><tfoot id='5C7D896C41'></tfoot></center><abbr id='5C7D896C41'><dir id='5C7D896C41'><tfoot id='5C7D896C41'></tfoot><noframes id='5C7D896C41'>

    • <optgroup id='5C7D896C41'><strike id='5C7D896C41'><sup id='5C7D896C41'></sup></strike><code id='5C7D896C41'></code></optgroup>
        1. <b id='5C7D896C41'><label id='5C7D896C41'><select id='5C7D896C41'><dt id='5C7D896C41'><span id='5C7D896C41'></span></dt></select></label></b><u id='5C7D896C41'></u>
          <i id='5C7D896C41'><strike id='5C7D896C41'><tt id='5C7D896C41'><pre id='5C7D896C41'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:22
          Cambridge: AbbVie
          Ruby Wallau for STAT

          AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

          Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

          advertisement

          Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Why drug prescriptions should include diagnoses
          Why drug prescriptions should include diagnoses

          AdobeTheCovid-19pandemicisteachingusmanytragiclessonsalongwithsomeinstructiveones,liketheimportanceo

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Inflation cooled significantly in June, bringing price hikes close to normal levels

          1:39ProducepricesaredisplayedatagrocerystoreinBrooklyn,Feb.14,2023.XinhuaNewsAgencyviaGettyImagesCon